Sakagami M. In vitro, ex vivo and in vivo methods of lung absorption for inhaled drugs. Adv Drug Deliv Rev [Internet]. Elsevier B.V.; 2020;161–162:63–74. Available from: https://doi.org/10.1016/j.addr.2020.07.025.

Xu C, Wang Y, Guo Z, Chen J, Lin L, Wu J, et al. Pulmonary delivery by exploiting doxorubicin and cisplatin co-loaded nanoparticles for metastatic lung cancer therapy. J Control Release [Internet]. Elsevier; 2019;295:153–63. Available from: https://doi.org/10.1016/j.jconrel.2018.12.013.

Mohammadinejad R, Dehshahri A, Sagar Madamsetty V, Zahmatkeshan M, Tavakol S, Makvandi P, et al. In vivo gene delivery mediated by non-viral vectors for cancer therapy. J Control Release [Internet]. Elsevier; 2020;325:249–75. Available from: https://doi.org/10.1016/j.jconrel.2020.06.038.

Forest V, Pourchez J. Nano-delivery to the lung - by inhalation or other routes and why nano when micro is largely sufficient? Adv Drug Deliv Rev [Internet]. Elsevier; 2022;183:114173. Available from: https://doi.org/10.1016/j.addr.2022.114173.

Wang W, Fu F, Huang Z, Wang W, Chen M, Yue X, et al. Inhalable biomimetic protein corona-mediated nanoreactor for self-amplified lung adenocarcinoma ferroptosis therapy. ACS Nano. 2022;16:8370–87.

Article  CAS  PubMed  Google Scholar 

Mehta P, Kadam S, Pawar A, Bothiraja C. Dendrimers for pulmonary delivery: current perspectives and future challenges. New J Chem. Royal Society of Chemistry; 2019;43:8396–409.

Merckx P, Lammens J, Nuytten G, Bogaert B, Guagliardo R, Maes T, et al. Lyophilization and nebulization of pulmonary surfactant-coated nanogels for siRNA inhalation therapy. Eur J Pharm Biopharm [Internet]. Elsevier B.V.; 2020;157:191–9. Available from: https://doi.org/10.1016/j.ejpb.2020.09.011.

Suk JS, Kim AJ, Trehan K, Schneider CS, Cebotaru L, Woodward OM, et al. Lung gene therapy with highly compacted DNA nanoparticles that overcome the mucus barrier. J Control Release [Internet]. Elsevier B.V.; 2014;178:8–17. Available from: http://dx.doi.org/https://doi.org/10.1016/j.jconrel.2014.01.007.

Wang W, Huang Z, Huang Y, Zhang X, Huang J, Cui Y, et al. Pulmonary delivery nanomedicines towards circumventing physiological barriers: strategies and characterization approaches. Adv Drug Deliv Rev [Internet]. Elsevier; 2022;185:114309. Available from: https://doi.org/10.1016/j.addr.2022.114309.

Huckaby JT, Lai SK. PEGylation for enhancing nanoparticle diffusion in mucus. Adv Drug Deliv Rev. Elsevier B.V.; 2018;124:125–39.

Lee WH, Loo CY, Traini D, Young PM. Inhalation of nanoparticle-based drug for lung cancer treatment: advantages and challenges [Internet]. Asian J. Pharm. Sci. The Authors; 2015. p. 481–9. Available from: https://doi.org/10.1016/j.ajps.2015.08.009.

Herman L, De Smedt SC, Raemdonck K. Pulmonary surfactant as a versatile biomaterial to fight COVID-19. J Control Release [Internet]. Elsevier B.V.; 2022;342:170–88. Available from: https://doi.org/10.1016/j.jconrel.2021.11.023.

d’Angelo I, Conte C, La Rotonda MI, Miro A, Quaglia F, Ungaro F. Improving the efficacy of inhaled drugs in cystic fibrosis: challenges and emerging drug delivery strategies. Adv Drug Deliv Rev [Internet]. Elsevier B.V.; 2014;75:92–111. Available from:  https://doi.org/10.1016/j.addr.2014.05.008.

Kim V, Criner GJ. Chronic bronchitis and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;187:228–37.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Innes AL, Carrington SD, Thornton DJ, Kirkham S, Rousseau K, Dougherty RH, et al. Ex vivo sputum analysis reveals impairment of protease-dependent mucus degradation by plasma proteins in acute asthma. Am J Respir Crit Care Med. 2009;180:203–10.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tillie-Leblond I, Gosset P, Tonnel AB. Inflammatory events in severe acute asthma. Allergy Eur J Allergy Clin Immunol. 2005;60:23–9.

Article  CAS  Google Scholar 

Persson CGA. Role of plasma exudation in asthmatic airways. Lancet. 1986;328:1126–9.

Article  Google Scholar 

Chen S, Li L, Zhao C, Zheng J. Surface hydration: principles and applications toward low-fouling/nonfouling biomaterials. Polymer (Guildf). Elsevier Ltd; 2010;51:5283–93.

Muralidharan P, Mallory E, Malapit M, Don H, Mansour HM. Inhalable PEGylated phospholipid nanocarriers and PEGylated therapeutics for respiratory delivery as aerosolized colloidal dispersions and dry powder inhalers. Pharmaceutics. 2014;6:333–53.

Article  PubMed  PubMed Central  Google Scholar 

Ishida T, Kiwada H. Accelerated blood clearance of pegylated liposomes after repeated injection. Drug Deliv Syst. 2004;19:495–510.

Article  CAS  Google Scholar 

Lowe AB, McCormick CL. Synthesis and solution properties of zwitterionic polymers. Chem Rev. 2002;102:4177–89.

Article  CAS  PubMed  Google Scholar 

Shan W, Zhu X, Tao W, Cui Y, Liu M, Wu L, et al. Enhanced oral delivery of protein drugs using zwitterion-functionalized nanoparticles to overcome both the diffusion and absorption barriers. ACS Appl Mater Interfaces. 2016;8:25444–53.

Article  CAS  PubMed  Google Scholar 

Lababidi N, Ofosu Kissi E, Elgaher WAM, Sigal V, Haupenthal J, Schwarz BC, et al. Spray-drying of inhalable, multifunctional formulations for the treatment of biofilms formed in cystic fibrosis. J Control Release. 2019;314:62–71.

Article  CAS  PubMed  Google Scholar 

Deacon J, Abdelghany SM, Quinn DJ, Schmid D, Megaw J, Donnelly RF, et al. Antimicrobial efficacy of tobramycin polymeric nanoparticles for Pseudomonas aeruginosa infections in cystic fibrosis: formulation, characterisation and functionalisation with dornase alfa (DNase). J Control Release. Elsevier B.V.; 2015;198:55–61.

Salunke S, O’Brien F, Cheng Thiam Tan D, Harris D, Math MC, Ariën T, et al. Oral drug delivery strategies for development of poorly water soluble drugs in paediatric patient population [Internet]. Adv. Drug Deliv. Rev. The Authors; 2022. p. 114507. Available from: https://doi.org/10.1016/j.addr.2022.114507.

Bowman K, Leong KW. Chitosan nanoparticles for oral drug and gene delivery. Int J Nanomedicine. 2006;1:117–28.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang Y, Qiu Y, Sun A, Xiong Y, Tan H, Shi Y, et al. Dual-functional AIE fluorescent probes for imaging β-amyloid plaques and lipid droplets. Anal Chim Acta [Internet]. Elsevier Ltd; 2020;1133:109–18. Available from: https://doi.org/10.1016/j.aca.2020.07.073.

Wang W, Liu H, Huang Z, Fu F, Wang W, Wu L, et al. The effect of organic ligand modification on protein corona formation of nanoscale metal organic frameworks. Chinese Chem Lett [Internet]. Elsevier B.V.; 2022;33:4185–90. Available from: https://doi.org/10.1016/j.cclet.2022.02.052.

Cai R, Chen C. The crown and the scepter: roles of the protein corona in nanomedicine. Adv Mater. 2019;31:1–13.

Article  Google Scholar 

Wang G, Wang W, Shangguan E, Gao S, Liu Y. Effects of gold nanoparticle morphologies on interactions with proteins. Mater Sci Eng C [Internet]. Elsevier; 2020;111:110830. Available from: https://doi.org/10.1016/j.msec.2020.110830.

Yang H, Wang M, Zhang Y, Liu X, Yu S, Guo Y, et al. Detailed insight into the formation of protein corona: conformational change, stability and aggregation. Int J Biol Macromol. 2019;135:1114–22.

Article  CAS  PubMed  Google Scholar